Acute demyelinating optic neuritis

Current Opinion in Ophthalmology

Volumn 13, Issue 6, 2002, Pages 375-380

  Foroozan, Rod ^a   Buono, Lawrence M ^a   Savino, Peter J ^a   Sergott, Robert C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYELIN BASIC PROTEIN; PLACEBO; PREDNISONE;

AFFERENT PUPILLARY DEFECT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; COLOR VISION; CONTRAST SENSITIVITY; DEMYELINATING DISEASE; DISEASE ASSOCIATION; EYE FUNDUS; EYE PAIN; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; VISUAL ACUITY; VISUAL FIELD DEFECT;

ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; DEMYELINATING DISEASES; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; OPTIC NEURITIS; VISUAL ACUITY; VISUAL FIELDS;

EID: 0036892913     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200212000-00006     Document Type: Review

References (16)

1. Rodriguez M, Cross SA, et al: Optic neuritis: A population-based study in Olmsted County, MN. Neurology 1995, 45:244-250.
2. Optic Neuritis Study Group: The clinical profile of optic neuritis. Arch Ophthalmol 1991, 109:1673-1678.
3. Beck RW, Cleary PA, Anderson MM Jr, et al: A randomized controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992, 326:581-588.
4. Swartz NG, Beck RW, Savino PJ, et al: Pain in anterior ischemic optic neuropathy. J Neuro-Ophthalmol 1995, 15:9-10.
5. Keltner JL, Johnson CA, Spurr JO, et al: Baseline visual field profile of optic neuritis: The experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1993, 111:231-234.
6. Beck RW, Kupersmith MJ, Cleary PA, et al: Fellow eye abnormalities in acute unilateral optic neuritis. Ophthalmology 1993, 100:691-698.
7. Keltner JL, Johnson CA, Spurr JO, et al: Visual field profile of optic neuritis: One year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol 1994, 112:946-953.
8. Beck RW, Optic Neuritis Study Group: The optic neuritis treatment trial. Arch Ophthalmol 1988, 106:1051-1053.
9. Beck RW, Cleary PA, Optic Neuritis Study Group: Optic neuritis treatment trial: One year follow-up results. Arch Ophthalmol 1993, 111:773-775.
10. Beck RW: The Optic Neuritis Treatment Trial: Three year follow-up results. Arch Ophthalmol 1995, 113:136-137.
11. Optic Neuritis Study Group: The five-year risk of multiple sclerosis after optic neuritis: Experience of the Optic Neuritis Treatment Trial. Neurology 1997, 49:1404-1413.
12. Beck RW, Arrington J, Murtagh R, et al: Brain magnetic resonance imaging in acute optic neuritis. Arch Neurol 1993, 50:841-846.
13. Beck RW, Cleary PA, Trobe JD, et al: The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993, 329:1764-1769.
14. Jacobs LD, Beck RW, Simon JH, et al: Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000, 343:898-904.
15. Jacobs LD, Cookfair DL, Rudick RA, et al: Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996, 39:285-294.
16. CHAMPS Group: Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol 2001, 132:463-471.